MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/0284186x.2023.2259597

Медицинская библиотека · Acta oncologica (Stockholm, Sweden) · 2023

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Spampinato Sofia, Rancati Tiziana, Waskiewicz Justyna Magdalena, Avuzzi Barbara, Garibaldi Elisabetta, Faiella Adriana, Villa Elisa, Magli Alessandro, Cante Domenico, Girelli Giuseppe, Gatti Marco, Noris Chiorda Barbara, Rago Luciana, Ferrari Paolo, Piva Cristina, Pavarini Maddalena, Valdagni Riccardo, Vavassori Vittorio, Munoz Fernando, Sanguineti Giuseppe, Di Muzio Nadia, Kirchheiner Kathrin, Fiorino Claudio, Cozzarini Cesare

СтатьяПеревод в очереди

Аннотация

PURPOSE: To evaluate the persistence of symptoms after radiotherapy (RT) for localised prostate cancer (PCa) and the association with quality of life (QOL).

MATERIALS AND

METHODS

Prospective patient-reported outcome (PRO) from a multi-institutional study on PCa treated with radical RT (2010-2014) was analysed. Data was collected at baseline (BL) and follow-ups (FUPs) up to 5 years. Patients with BL and ≥3 late FUPs (≥6 months) were analysed. PRO was scored by means of the IPSS and ICIQ-SF (urinary), LENT-SOMA (gastrointestinal [GI]), and EORTC-C30 (pain, insomnia, fatigue, and QOL) questionnaires. Symptoms were defined 'persistent' if the median score over FUPs was ≥3 (urinary) or ≥2 (GI, pain, insomnia, and fatigue), and worse than BL. Different thresholds were chosen to have enough events for each symptom. QOL was linearly transformed on a continuous scale (0-100). Linear-mixed models were used to identify significant differences between groups with and without persistent symptoms including age, smoking status, previous abdominal surgery, and diabetes as confounders. Mean QOL differences between groups were evaluated longitudinally over FUPs.

RESULTS

The analysis included 293 patients. Persistent urinary symptoms ranged from 2% (straining) to 12% (weak stream, and nocturia). Gastrointestinal symptoms ranged from 7% (rectal pain, and incontinence) to 30% (urgency). Proportions of pain, insomnia, and fatigue were 6, 13, and 18%. Significant QOL differences of small-to-medium clinical relevance were found for urinary incontinence, frequency, urgency, and nocturia. Among GI symptoms, rectal pain and incontinence showed small-to-medium differences. Fatigue was associated with the largest differences.

CONCLUSIONS

The analysis showed that symptoms after RT for PCa occur with different persistence and their association with QOL varies in magnitude. A number of persistent urinary and GI symptoms showed differences in a comparable range. Urinary incontinence and frequency, rectal pain, and faecal incontinence more often had significant associations. Fatigue was also prevalent and associated with largely deteriorated QOL.

Для цитирования: Spampinato Sofia, Rancati Tiziana, Waskiewicz Justyna Magdalena, Avuzzi Barbara, Garibaldi Elisabetta, Faiella Adriana, Villa Elisa, Magli Alessandro, Cante Domenico, Girelli Giuseppe, Gatti Marco, Noris Chiorda Barbara, Rago Luciana, Ferrari Paolo, Piva Cristina, Pavarini Maddalena, Valdagni Riccardo, Vavassori Vittorio, Munoz Fernando, Sanguineti Giuseppe, Di Muzio Nadia, Kirchheiner Kathrin, Fiorino Claudio, Cozzarini Cesare. Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.. Acta oncologica (Stockholm, Sweden). 2023. DOI: 10.1080/0284186x.2023.2259597.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.